The main program of Zoltan Laboratories, LLC (Zoltan Labs) is to develop
recombinant PLAP for reducing or even reversing muscle wasting and key
metabolic disorders caused by cancer, cancer treatments, obesity, diabetes,
and/or old age. Older people who have cancer or are obese and/or type 2
diabetic are in the greatest need to control muscle wasting by PLAP.
Along with reducing loss of muscle proteins and muscle strength, injected PLAP also
will improve bone marrow function in cancer patients treated with chemotherapy and/or
Zoltan Labs’ is also working on healing of diabetic wounds; this program is at an early